Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases

Jazz Pharmaceuticals plc Ireland California

View original content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-announces-pricing-of-private-offering-of-850-million-of-3-125-exchangeable-senior-notes-due-2030-and-concurrent-ordinary-share-repurchases-302237490.html